FDA.reportPublic FDA data

dalbavancin

RxCUI
1539239
RxNorm name
dalbavancin
Term type
IN
Status
Active
Updated
2026-06-04 07:08:23

RxNorm Status History#

Status
Active
Source
RXNORM
Current
YES
Release start
072014
Active start
072014
Multiple ingredient
NO
Branded
NO

Source Vocabulary Codes#

Code type, Value, Category table
Code typeValueCategory
PRESCRIBABLEYATTRIBUTES
RXNAV_STRdalbavancinNAMES
RxNorm NamedalbavancinNAMES
TTYINATTRIBUTES
SPL_SET_ID1f4a5924-96d7-445a-b75f-2c0e1ffd2deaCODES
SPL_SET_ID2a20d077-a5ba-4af3-a2d6-499c25b816d8CODES
SPL_SET_ID2c2ec45e-48a2-4887-8ab0-9244eb39a394CODES
SPL_SET_ID4b4674d8-4d1e-4728-8465-d42ada33fa5cCODES
SPL_SET_ID966995bb-9d92-434d-b75a-1786072b81c9CODES
UNII_CODE808UI9MS5KCODES
RxCUI1539239CODES
MMSL_CODEBN399068CODES
MMSL_CODEGNd08264CODES

UNII Substances#

UNII, Preferred term, Registry number table
UNIIPreferred termRegistry numberSource
808UI9MS5KDALBAVANCIN171500-79-1tbl_unii_list
808UI9MS5KDALBAVANCIN171500-79-1tbl_unii_list

Drug Classes#

Source, Class ID, Class table
SourceClass IDClassTypeRelationshipDrug concept
ATCJ01XAGlycopeptide antibacterialsATC1-4dalbavancin
FDASPLD000077427LipoglycopeptidesCHEMhas_chemical_structuredalbavancin
FDASPLN0000191281Lipoglycopeptide AntibacterialEPChas_epcdalbavancin
MEDRTD017334TeicoplaninCHEMhas_ingredientdalbavancin
MEDRTD004342Drug HypersensitivityDISEASEci_withdalbavancin
MEDRTD004342Drug HypersensitivityDISEASEci_withdalbavancin hydrochloride
MEDRTD012874Skin Diseases, InfectiousDISEASEmay_treatdalbavancin
MEDRTD012874Skin Diseases, InfectiousDISEASEmay_treatdalbavancin hydrochloride
MEDRTD013203Staphylococcal InfectionsDISEASEmay_treatdalbavancin
MEDRTD013203Staphylococcal InfectionsDISEASEmay_treatdalbavancin hydrochloride
MEDRTD013290Streptococcal InfectionsDISEASEmay_treatdalbavancin
MEDRTD013290Streptococcal InfectionsDISEASEmay_treatdalbavancin hydrochloride
MEDRTN0000000150Protein Synthesis InhibitorsMOAhas_moadalbavancin
MEDRTN0000000150Protein Synthesis InhibitorsMOAhas_moadalbavancin hydrochloride
MEDRTN0000008479Decreased Cell Wall Synthesis & RepairPEhas_pedalbavancin
MEDRTN0000008479Decreased Cell Wall Synthesis & RepairPEhas_pedalbavancin hydrochloride

Properties#

Category, Property, Value table
CategoryPropertyValue
ATTRIBUTESGENERAL_CARDINALITYSINGLE
ATTRIBUTESPRESCRIBABLEY
ATTRIBUTESRXNAV_HUMAN_DRUGUS
ATTRIBUTESTTYIN
CODESATCJ01XA04
CODESDRUGBANKDB06219
CODESMMSL_CODEBN399068
CODESMMSL_CODEGNd08264
CODESRxCUI1539239
CODESSNOMEDCT703917001
CODESSNOMEDCT703919003
CODESSPL_SET_ID1f4a5924-96d7-445a-b75f-2c0e1ffd2dea
CODESSPL_SET_ID2a20d077-a5ba-4af3-a2d6-499c25b816d8
CODESSPL_SET_ID2c2ec45e-48a2-4887-8ab0-9244eb39a394
CODESSPL_SET_ID4b4674d8-4d1e-4728-8465-d42ada33fa5c
CODESSPL_SET_ID966995bb-9d92-434d-b75a-1786072b81c9
CODESUNII_CODE808UI9MS5K
CODESVUID4025243
NAMESRXNAV_STRdalbavancin
NAMESRxNorm Namedalbavancin
SOURCESSourceAnatomical Therapeutic Chemical
SOURCESSourceDrug Bank
SOURCESSourceGold Standard Alchemy
SOURCESSourceMetathesaurus FDA Structured Product Labels
SOURCESSourceMultum MediSource Lexicon
SOURCESSourceNational Drug Data File Plus Source Vocabulary
SOURCESSourceUS Edition of SNOMED_CT
SOURCESSourceVeterans Health Administration National Drug File